Skip to content
Screener

Artivion AORT Stock-Based Comp

Stock-Based Comp at other companies

Abbott logo
AbbottABT
$168M+18.3%
Edwards Lifesciences logo
Edwards LifesciencesEW
$45.4M+12.9%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$1.94M-0.5%
Medtronic logo
MedtronicMDT
$95M+6.7%
ITG
Integer HoldingsITGR
$6.66M-3.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%

Other financials

Income statement

See full
Revenue$125.8M+11.3%
Gross profit$80.5M+10.1%
Operating income-$8.4M-200%
Net income-$13.5M-1,104%
EPS (diluted)-$0.28-1,033%

Balance sheet

See full
Cash & equivalents$77.3M+44.6%
Total debt$408.0M+54.7%
Total equity$445.6M+6.1%
Total assets$1.1B+27.9%

Cash flow

See full
Operating cash flow-$1.3M-108%
CapEx$10.7M+227%
Free cash flow-$12.0M

Valuation

See full
Market cap$1.28B-33.5%
Enterprise value$1.61B-24.6%
P/S2.7×-2.0×

Profitability

See full
Gross margin64.4%+0.4pp
Operating margin4.4%0.0pp
Net margin-0.7%-0.3pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity-0.7%-0.3pp
Debt / equity0.9×+0.3×
Current ratio3.5×-1.3×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Artivion’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 1:57 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054746
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net (loss) income$(12,093)$840
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization13,08810,984
Non-cash compensation16,57814,167
Non-cash lease expense2,6122,510
Write-down of inventories and deferred preservation costs2,3682,379
Deferred income taxes(1,421)(231)
Change in fair value of contingent consideration9,710(210)

Item 1. Financial Statements.

FAQ

What is Artivion's stock-based comp?
Artivion (AORT) reported stock-based comp of $8.16M in Q2 2026.
How has Artivion's stock-based comp changed year-over-year?
Artivion's stock-based comp increased by 33.4% year-over-year, from $6.12M to $8.16M.
What is the long-term trend for Artivion's stock-based comp?
Over 4 years (2021 to 2025), Artivion's stock-based comp has grown at a 22.8% compound annual growth rate (CAGR), from $10.71M to $24.39M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Artivion's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude